Omicron surges in Europe as Italy and Spain tighten restrictions – BBC News
Italy and Spain are the latest European countries to tighten coronavirus restrictions in an effort to curb the spread of…
Diabetes, lung and heart disease common in U.S. coronavirus patients: CDC
(Reuters) – Diabetes, heart disease and long-term lung problems are the most common underlying conditions among Americans hospitalized with the…
Biogen scraps development of therapy for rare brain disease
(Reuters) – Biogen Inc said on Friday it would discontinue the development of its experimental therapy for a rare brain…
AstraZeneca succeeds in treating lupus in late-stage study
The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock…
Lilly’s pancreatic cancer treatment fails late-stage study
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the…
Retrophin scraps nervous system disorder study, shares dive
(Reuters) – Retrophin Inc said on Thursday it was discontinuing the late-stage study for its rare neurological disorder treatment after…
GSK builds oncology pipeline as drug shown to help myeloma patients
(Reuters) – GlaxoSmithKline said an experimental multiple myeloma treatment has shown a meaningful response in patients that have run out…
VBI’s shares plunge after hep B vaccine fails secondary goal in late-stage trial
(Reuters) – VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis…
Enanta’s lung infection therapy succeeds in mid-stage trial
(Reuters) – Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal…
Abbott device helps in cutting blood sugar in type 2 diabetics: study
(Reuters) – Insulin-dependent patients with type 2 diabetes saw a significant drop in their blood sugar levels after wearing Abbott…
Takeda scraps late-stage amyloidosis study
FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon/File…
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
(Reuters) – A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet…
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
(Reuters) – A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet…
BrainStorm gets FDA okay for stem cell trial in MS patients
TEL AVIV (Reuters) – BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin…
Evofem shares surge as contraceptive gel meets late-stage trial goal
(Reuters) – Shares of Evofem Biosciences Inc jumped as much as 38 percent on Monday after its birth control gel…
Johnson & Johnson’s multiple myeloma drug reduces risk of death in late-stage study
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake (Reuters) –…
Lilly’s diabetes drug data impresses, hurts rival Novo’s shares
(Reuters) – Eli Lilly and Co (LLY.N) said on Thursday its new two-in-one diabetes drug was successful in lowering blood…
Turkish lira fall: who’s responsible?: BBC News Review
US says it is ‘not responsible’ for the Turkish lira’s dramatic fall. Turkey accuses the US of ‘stabbing it in…
Mersana’s cancer drug trial put on hold by FDA; shares halted
(Reuters) – Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on…
Allergan, Molecular Partners eye drug meets main goal in two studies
(Reuters) – Allergan Plc and Molecular Partners AG said on Thursday their treatment for neovascular age-related macular degeneration, a leading…
Pfizer-Lilly pain drug meets late-stage trial goals
(Reuters) – An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of…
CTI Biopharma’s cancer drug fails late-stage trial, shares tumble
(Reuters) – CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the…
SAT exam draws China students to Hong Kong
Tens of thousands of students from mainland China are flocking to Hong Kong to take the SAT exam in the…
PAKISTAN: Overachievers set the bar high for international exams
Pakistani student Haroon Tariq has broken the current world record by securing a total of 47 “A”s in the Cambridge…
Microplastics found in most bottled water tested in global study
The perception of bottled water being clean and pure is being challenged by a global investigation that found the water…
SINGAPORE: NS for women?
Not many women in Singapore have had the chance to experience National Service, or NS, unlike their male counterparts. And…
SINGAPORE: Master of Science in Audiology degree course launched at NUS
A new Master of Science in Audiology degree course has been officially launched at the National University of Singapore (NUS).…
A Former Hotel In Milwaukee Is Now Home To 170 Chinese Teen Students (HBO)
The number of Chinese students enrolling at American secondary schools is on the rise–and if the success of the Wisconsin…
Merck’s Keytruda helps lung cancer patients live longer in trial
(Reuters) – Merck & Co’s (MRK.N) blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage…
Lilly’s Cyramza succeeds in late-stage liver cancer trial
(Reuters) – Eli Lilly and Co on Wednesday said its drug Cyramza met the main goal of helping patients live…
Esperion’s drug clears study as add-on cholesterol treatment
(Reuters) – Esperion Therapeutics Inc said on Tuesday its experimental oral drug met the main goal of reducing cholesterol by…
Biohaven plunges as investors pit migraine data against Allergan’s drug
(Reuters) – Biohaven Pharmaceutical Holding said its treatment for acute migraine cleared two late-stage studies, but investors worried about its…
AbbVie’s lung cancer drug data disappoints; shares slump
(Reuters) – AbbVie Inc’s experimental lung cancer drug data was not effective enough to seek a faster approval, in a…